The Health Sciences Authority (HSA) invites public feedback on proposed amendments to Regulation 23 of the Health Products (Therapeutic Products) Regulations on patent declaration. The public consultation will run from 1 March 2024 to 31 March 2024.
HSA and the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea signed a Mutual Recognition Agreement today on the establishment of requirements for Good Manufacturing Practice (GMP) for medicinal products.